T1	Participants 230 291	Patients who survive life-threatening ventricular arrhythmias
T2	Participants 607 756	patients who had been resuscitated from near-fatal ventricular fibrillation or who had undergone cardioversion from sustained ventricular tachycardia
T3	Participants 758 919	Patients with ventricular tachycardia also had either syncope or other serious cardiac symptoms, along with a left ventricular ejection fraction of 0.40 or less.
T4	Participants 1150 1267	patients who presented with ventricular tachycardia or ventricular fibrillation during a period of nearly four years.
T5	Participants 1268 1499	Of 1016 patients (45 percent of whom had ventricular fibrillation, and 55 percent ventricular tachycardia), 507 were randomly assigned to treatment with implantable cardioverter-defibrillators and 509 to antiarrhythmic-drug therapy
